CWM
LRCX icon

Concentrum Wealth Management’s Lam Research LRCX Stock Holding History

Concentrum Wealth Management’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+503
New +$153K 0.05% 120

Other funds holding LRCX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concentrum Wealth Management's LRCX Position: Q2 2026 in Review

Concentrum Wealth Management opened a new position in Lam Research (LRCX) in Q2 2026: 503 shares worth $218K. The stake represents 0.05% of the portfolio and ranks #120 among its holdings.

3,114 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Concentrum Wealth Management held 503 shares of Lam Research worth $218K as of Q2 2026.
  • Lam Research was a new Concentrum Wealth Management position in Q2 2026.
  • Lam Research made up 0.05% of Concentrum Wealth Management's portfolio in Q2 2026, its #120 holding.
  • 3,114 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Concentrum Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.